← Eichor
Condition: Preventive Treatment Of Migraine Synced from ClinicalTrials.gov · July 27, 2026

Recruiting studies: Preventive Treatment Of Migraine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
Phase 2 · 6 location(s) · St. Olavs Hospital · NCT06485336Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Phase 2 · 6 location(s) · St. Olavs Hospital · NCT06248671A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual
Phase 3 · 123 location(s) · Pfizer · NCT06641466Idebenone for the Preventive Treatment of Migraine
Phase 3 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04151472nVNS for the Prevention and Treatment of Primary Headache
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06277063Cannabis for the Prophylactic Treatment of Migraine
Phase 2 · 1 location(s) · University of Calgary · NCT03972124Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Phase 4 · 15 location(s) · Upsher-Smith Laboratories · NCT04748601Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of
Phase 2 · 5 location(s) · Centre Hospitalier Universitaire de Nice · NCT04063540Study of EVO756 in Adults With Migraine
Phase 2 · 14 location(s) · Evommune, Inc. · NCT07616128A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Phase 3 · 84 location(s) · H. Lundbeck A/S · NCT04965675Neuro-Complex & Multi Supplements for Migraine Prevention
NA · 1 location(s) · Benfida, a department of Handi-Move · NCT07015411Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration
NA · 2 location(s) · The Hong Kong Polytechnic University · NCT05690737TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
Phase 3 · 6 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05484349Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Phase 4 · 35 location(s) · Mayo Clinic · NCT06972056Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06659120Cabergoline for Episodic Migraine
Phase 2 · 1 location(s) · Aarhus University Hospital · NCT07072910A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Partici
Phase 3 · 64 location(s) · AbbVie · NCT06810505MMA Embolization for Refractory Chronic Migraine
NA · 9 location(s) · Cerenovus, Part of DePuy Synthes Products, Inc. · NCT06735833A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · 108 location(s) · Merz Therapeutics GmbH · NCT07018700Efficacy of Nerve Blocks for Episodic Migraine
Phase 2 · 1 location(s) · Mayo Clinic · NCT05734625A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Phase 2 · 166 location(s) · Ipsen · NCT06625060Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine
NA · 1 location(s) · Abilion Medical Systems AB · NCT07279623Sleep, Stress and Migraine - an Observational and Training Study
NA · 1 location(s) · Susanne Wegener · NCT07573488Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Preve
Phase N/A · 36 location(s) · AbbVie · NCT06603558A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants
Phase 3 · 98 location(s) · AbbVie · NCT05711394Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
Phase N/A · 1 location(s) · Uniformed Services University of the Health Sciences · NCT07267819Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · 90 location(s) · Pfizer · NCT05156398Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Phase N/A · 26 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07159750A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · 109 location(s) · Merz Therapeutics GmbH · NCT07018713A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Phase 3 · 102 location(s) · Pfizer · NCT06616194
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.